KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBITDA Margin: 2017-2025

Historic EBITDA Margin for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -25.59%.

  • Moderna's EBITDA Margin fell 2183.00% to -25.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -155.15%, marking a year-over-year decrease of 10146.00%. This contributed to the annual value of -121.91% for FY2024, which is 6001.00% down from last year.
  • Per Moderna's latest filing, its EBITDA Margin stood at -25.59% for Q3 2025, which was up 95.99% from -638.73% recorded in Q2 2025.
  • Moderna's 5-year EBITDA Margin high stood at 75.02% for Q4 2021, and its period low was -972.22% during Q1 2025.
  • Over the past 3 years, Moderna's median EBITDA Margin value was -128.99% (recorded in 2024), while the average stood at -361.26%.
  • In the last 5 years, Moderna's EBITDA Margin surged by 170,286bps in 2021 and then crashed by 73,843bps in 2024.
  • Moderna's EBITDA Margin (Quarterly) stood at 75.02% in 2021, then crashed by 4,395bps to 31.08% in 2022, then slumped by 3,086bps to 0.21% in 2023, then plummeted by 12,920bps to -128.99% in 2024, then crashed by 2,183bps to -25.59% in 2025.
  • Its EBITDA Margin was -25.59% in Q3 2025, compared to -638.73% in Q2 2025 and -972.22% in Q1 2025.